default author photo

Max Bulsara

University of Notre Dame Australia - Institute for Health Research

29 Shepherd St. Level 1

Sydney , New South Wales 2008

Australia

SCHOLARLY PAPERS

4

DOWNLOADS

312

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Cumulative Local Recurrence Rate is a Misleading and Non-Representative Outcome Measure for Early Breast Cancer Trials

Number of pages: 9 Posted: 26 Nov 2024
University College London - Division of Surgery and Interventional Science, University of Notre Dame Australia - Institute for Health Research, University of Oxford, University of Nottingham, University of Oxford, Russell Investment Group (London), University College London - Division of Medicine, University College London - Division of Surgery and Interventional Science and University College London Hospitals - Department of Clinical Oncology
Downloads 117 (608,822)

Abstract:

Loading...

Local recurrence, breast cancer, radiotherapy, Kaplan-Meier, misleading graphs

2.

Initial Outcome of the TARGIT-B International Randomised Trial of Targeted Intraoperative Radiotherapy Tumour Bed Boost for Young or High-Risk Patients with Breast Cancer

Number of pages: 22 Posted: 27 Feb 2026
University College London - Division of Surgery and Interventional Science, University of Notre Dame Australia - Institute for Health Research, University College London Hospitals - Department of Clinical Oncology, University College London - Division of Surgery and Interventional Science, University College London - Division of Medicine, Yonsei University - Gangnam Severance Hospital, Gauteng Netcare Milpark Hospital, Gauteng Netcare Milpark Hospital, Centro di Riferimento Oncologico, Centro di Riferimento Oncologico, University Malaya Medical Centre, University Malaya Medical Centre, Universidad Fernando Pessoa Canarias, Hospitales Universitarios San Roque, Universidad Fernando Pessoa Canarias, Veneto Institute of Oncology IOV - IRCCS, Veneto Institute of Oncology IOV - IRCCS, Centre Georges-Francois Leclerc, Whittington Hospital, University College London Hospital - Department of Cellular Pathology, Imam Abdulrahman Bin Faisal University, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Institut Català d'Oncologia, Government of the United Kingdom - Great Western Hospitals, Government of the United Kingdom - Great Western Hospitals, Princess Alexandra Hospital, Princess Alexandra Hospital, Princess Alexandra Hospital, Princess Alexandra Hospital, Princess Alexandra Hospital, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Institut de Cancerologie de l’Ouest, Institut de Cancerologie de l’Ouest, Bergonié Institute, Bergonié Institute, Government of the United Kingdom - Royal Free London NHS Foundation Trust, Chulalongkorn University - King Chulalongkorn Memorial Hospital, Chulalongkorn University - King Chulalongkorn Memorial Hospital, Chulalongkorn University - King Chulalongkorn Memorial Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Northwell Health, Centre François Baclesse, Legacy Good Samaritan Medical Center, Guy's Hospital, Helen Rey Breast Cancer Research Foundation, Royal Hampshire County Hospital, Royal Hampshire County Hospital, Lakeland Health, NHS Lothian - St John’s Hospital, Aurora Baycare Medical Cente, Aurora Baycare Medical Cente, Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Brust-Zentrum Seefeld, Brust-Zentrum Seefeld, West Virginia University - West Virginia University Health Sciences Center, William Beaumont Hospital, William Beaumont Hospital, Centre Léon Berard, Memorial University Medical Center, Cleveland Clinic, University College London, University College London, Russell Investment Group (London), University College London and University of Oxford
Downloads 98 (725,554)

Abstract:

Loading...

breast cancer, radiotherapy, intraoperative radiotherapy, lumpectomy, wide local excision, breast conserving surgery, TARGIT-IORT, survival from breast cancer

3.

Global Adoption of Single-Shot Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Breast Cancer – Better for Patients, Better for Health Care Systems

Number of pages: 22 Posted: 28 Apr 2021
University College London - Division of Surgery and Interventional Science, University of Oxford, University College London - Division of Surgery and Interventional Science, University of Notre Dame Australia - Institute for Health Research, Sir Charles Gairdner Hospital - Department of Radiation Oncology, University College London Hospitals - Department of Clinical Oncology and Independent
Downloads 59 (970,490)
Citation 1

Abstract:

Loading...

4.

Excisional Treatment  Comparison For  ISitu  Endocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone Biopsy

Number of pages: 17 Posted: 15 Oct 2020
The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, The University of Sydney - Sydney Medical School, Canterbury Health Laboratories - Department of Anatomical Pathology, University of Notre Dame Australia - Institute for Health Research, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit, Westmead Hospital - Department of Gynaecological Oncology, University of Notre Dame Australia - Institute for Health Research, University of Notre Dame Australia - Institute for Health Research, Auckland City Hospital - Department of Gynaecological Oncology, King Edward Memorial Hospital - Department of Gynaecological Oncology, University of Otago - Department of Obstetrics and Gynaecology, Westmead Hospital - Department of Gynaecological Oncology, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, Auckland City Hospital - Department of Gynaecological Oncology, The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, University of Otago - Department of Obstetrics and Gynaecology, King Edward Memorial Hospital - Department of Histopathology, Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit, The University of Sydney - NHMRC Clinical Trials Centre, University of Otago - Department of Obstetrics and Gynaecology, Australia New Zealand Gynaecological Oncology Group, Clinipath Pathology, Osborne Park, Auckland City Hospital - Department of Gynaecological Oncology and Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit
Downloads 38 (1,209,354)

Abstract:

Loading...

Cervical adenocarcinoma in situ, AIS, cold knife cone biopsy, CKC, loop electrosurgical excision procedure, LEEP, LLETZ, cervical glandular dysplasia, excision biopsy cervix